Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590993 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging and Spectroscopy of the Prostate
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1,005
- Enrollment target
NCT00590993: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00590993 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,005 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00590993 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1,005 participants
- Enrollment target
Study Summary
Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks at structural and chemical properties of prostates in prostate cancer patients before and after treatment.
Interventions
- OTHER MRI and MRSI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,005 participants |
| Start Date | 2000-12 |
| Est. Completion | 2013-02 |
What the finished NCT00590993 record still lists
NCT00590993 is an observational study that tracks outcomes without assigning an intervention. Its 1,005 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which MRI and MRSI is the first listed.
NCT00590993 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00590993 about?
NCT00590993 is a clinical study titled "Magnetic Resonance Imaging and Spectroscopy of the Prostate". Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks...
What is the current status of trial NCT00590993?
This trial is currently completed. The enrollment target is 1,005 participants. The study started on 2000-12. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00590993?
The interventions under investigation include: MRI and MRSI (OTHER).
Who is sponsoring clinical trial NCT00590993?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia